Filing Details

Accession Number:
0001209191-16-110127
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-03-22 21:00:35
Reporting Period:
2016-03-22
Filing Date:
2016-03-22
Accepted Time:
2016-03-22 21:00:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411158 Anacor Pharmaceuticals Inc. ANAC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202769 L Paul Berns C/O Anacor Pharmaceuticals, Inc.
1020 East Meadow Circle
Palo Alto CA 94303
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-03-22 9,700 $59.89 258,111 No 4 S Direct
Common Stock Disposition 2016-03-22 27,800 $60.46 230,311 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person to cover taxes associated with the vesting of restricted stock units.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.28 to $60.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.28 to $60.75, inclusive.